Family Medicine · Palmdale, CA
NPI
1699953604
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
38780 Trade Center Dr # 1c
Palmdale, CA, 93551
Phone (661) 947-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$494K
4,813 services
Medicare patients, 2024
245
Average age 76
Drug cost, 2024
$2.3M
4,637 prescriptions
Company payments, 2025
$299
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Svetlana Gorelikova was code 99213 (office e&m - established), 906 times for 215 patients. In total Svetlana Gorelikova billed 4,813 services in 34 codes, and Medicare paid $494K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 906 | 215 | $67.85 | $61K |
| 93923 Duplex Scan - Extremity Arteries | Office | 330 | 165 | $93.23 | $31K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 304 | 196 | $156.08 | $47K |
| 93978 Duplex Scan - Extremity Arteries | Office | 283 | 191 | $135.26 | $38K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 279 | 190 | $95.03 | $27K |
| 93886 Ultrasound - Nonspecific | Office | 237 | 178 | $228.94 | $54K |
| 93925 Duplex Scan - Extremity Arteries | Office | 231 | 192 | $192.71 | $45K |
| 93970 Duplex Scan - Extremity Veins | Office | 230 | 189 | $122.89 | $28K |
| 96116 Behavioral Health Services | Office | 219 | 173 | $70.37 | $15K |
| 93930 Duplex Scan - Extremity Arteries | Office | 206 | 165 | $152.60 | $31K |
| 76800 Ultrasound - Nonspecific | Office | 204 | 175 | $120.74 | $25K |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 179 | 145 | $70.10 | $13K |
| 36415 Venipuncture Blood Collection | Office | 151 | 116 | $5.88 | $888 |
| 99214 Office E&M - Established | Office | 136 | 116 | $86.33 | $12K |
| 76881 Ultrasound - Nonspecific | Office | 128 | 61 | $41.68 | $5,335 |
By year: 2022 $570K for 5,718 services; 2023 $614K for 5,713 services; 2024 $494K for 4,813 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 151 | 116 | $5.88 | $888 |
Medicare prescription drug claims, 2024
In 2024, the drug Svetlana Gorelikova prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 201 prescriptions and refills. In total Svetlana Gorelikova wrote 4,637 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 201 | 201 | 55 | $6,546 |
| Oxycodone Hcl Generic | 180 | 180 | 42 | $7,364 |
| Creon Lipase/Protease/Amylase | 135 | 211 | 28 | $484K |
| Atorvastatin Calcium Generic | 134 | 282 | 44 | $1,165 |
| Gabapentin Generic | 114 | 150 | 40 | $1,202 |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 111 | 259 | 27 | $161K |
| Diclofenac Potassium Generic | 82 | 130 | 22 | $394K |
| Lidocaine Generic | 81 | 152 | 18 | $11K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 79 | 79 | 30 | $2,396 |
| Tamsulosin Hcl Generic | 70 | 117 | 23 | $733 |
| Linzess Linaclotide | 64 | 114 | 25 | $58K |
| Xarelto Rivaroxaban | 63 | 153 | 21 | $83K |
| Mounjaro Tirzepatide | 62 | 62 | 21 | $62K |
| Diclofenac Sodium Generic | 61 | 87 | 19 | $1,648 |
| Omeprazole Generic | 61 | 99 | 22 | $419 |
Brand drugs: 1,098 claims; generic drugs: 3,475 claims; opioid claims: 550.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Svetlana Gorelikova $299 ($299 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $221.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.